Jones Hill Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Jones Hill Capital's ANIP Position: Q3 2026 in Review
Jones Hill Capital sold out of ANI Pharmaceuticals (ANIP) in Q3 2026, closing a stake of 233,808 shares — an estimated $19.4M sold.
Jones Hill Capital first reported a position in ANIP in Q1 2026 and held it in 2 quarters. The position peaked at $24.5M in Q1 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Jones Hill Capital reported no remaining ANI Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Jones Hill Capital sold 233,808 ANI Pharmaceuticals shares in Q3 2026, an estimated $19.4M.
- Jones Hill Capital first reported a position in ANI Pharmaceuticals in Q1 2026 and held it in 2 quarters.
- Jones Hill Capital's ANI Pharmaceuticals position peaked at $24.5M in Q1 2026.
- 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Jones Hill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.